ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

NCI Reports On Efforts To Prevent Cancer In Native Americans

August 13, 1999

National Action Plan: Steering committee Votes No Confidence In HHS Official.

August 15, 1997

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005